为了正常的体验网站,请在浏览器设置里面开启Javascript功能!

长春达兴药业股份有限公司

2017-11-28 4页 doc 19KB 10阅读

用户头像

is_882336

暂无简介

举报
长春达兴药业股份有限公司长春达兴药业股份有限公司 The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in...
长春达兴药业股份有限公司
长春达兴药业股份有限公司 The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. 長春達興药業股份有限公司 Changchun Da Xing Pharmaceutical Company Limited (a joint stock limited company incorporated in the People’s Republic of China) (Stock Code :8067) RECEIVE OF HKEX LETTER, SENTENCE OF FORMER CHAIRMAN AND CFO The Company has received, on January 8, 2008, a letter from HKEx, with the notice of the decision from HKEx to cancel the listing of the Company’s H Shares. The GEM Listing Committee has decided that the listing of the H Shares of the Company on the Exchange be cancelled in accordance with Rule 9.14 of the GEM Listing Rules. The Company’s legal agent has filed a petition on the decision. On January 18, 2008, HKEx Review Committee notified the Company to attend a review meeting on February 26, 2008, at 4:30pm. The Company will propose a detailed and viable merger plan, the goal is to delay the de-listing and ultimately resume its listing. As the judgment by Jilin Nong’an County Court, the Company’s former Chairman, Mr. Feng, Zhenwen is sentenced of 3 years imprisonment for disclosing false financial statement and misappropriate the Company’s assets, the Company’s former Chief Financial Officer, Ms. Li, Xiujie is sentenced of 4 years imprisonment for disclosing false financial statement and misappropriate the Company’s assets. The Company has received, on January 8, 2008, a letter from HKEx, with the notice of the decision from HKEx to cancel the listing of the Company’s H Shares. The GEM Listing Committee has decided that the listing of the H Shares of the Company on the Exchange be cancelled in accordance with Rule 9.14 of the GEM Listing Rules. The Company’s legal agent has filed a petition on the decision. On January 18, 2008, HKEx Review Committee notified the Company to attend a review meeting on February 26, 2008, at 4:30pm. The Company will propose a detailed and viable merger plan, the goal is to delay the de-listing and ultimately resume its listing. As the judgment by Jilin Nong’an County Court on February 8, 2007, the Company’s former Chairman, Mr. Feng, Zhenwen is sentenced of 2 years imprisonment and a fine of RMB20,000 for disclosing false financial statement, and 2 years imprisonment for misappropriate the Company’s assets, the court has ordered a total of 3 years imprisonment and a fine of RMB20,000 for Mr. Feng. As the judgment by Jilin Nong’an County Court on February 8, 2007, the Company’s former Chief Financial Officer, Ms. Li, Xiujie is sentenced of 2 years imprisonment and a fine of RMB20,000 for disclosing false financial statement, and 3 years imprisonment for misappropriate the Company’s assets, the court has ordered a total years imprisonment and a fine of RMB20,000 for Ms. Li of 4 At the request of the Company, trading in the shares of the Company on the Stock Exchange was suspended with effect from 10:00 a.m. on 28 July 2005 and will remain suspended until further notice. By order of the Board Changchun Da Xing Pharmaceutical Company Limited Guo Gan ____________ Director Changchun, the PRC, 18 January 2008 As at the date of this announcement, the Board comprises Mr. Guo Gan only. This announcement, for which the directors of Changchun Da Xing Pharmaceutical Company Limited collectively and individually accept full responsibility, includes particulars given in compliance with the Rules Governing the Listing of Securities on the Growth Enterprise Market of The Stock Exchange of Hong Kong Limited for the purpose of giving information with regard to Changchun Da Xing Pharmaceutical Company Limited. The directors, having made all reasonable enquiries, confirm that, to the best of their knowledge and belief: (1) the information contained in this announcement is accurate and complete in all material respects and not misleading; (2) there are no other matters the omission of which would make any statement in this announcement misleading; and (3) all opinions expressed in this announcement have been arrived at after due and careful consideration and are founded on bases and assumptions that are fair and reasonable. This announcement will remain on the “Latest Company Announcements” page on the GEM Website at www.hkgem.com for at least 7 days from the date of its posting.
/
本文档为【长春达兴药业股份有限公司】,请使用软件OFFICE或WPS软件打开。作品中的文字与图均可以修改和编辑, 图片更改请在作品中右键图片并更换,文字修改请直接点击文字进行修改,也可以新增和删除文档中的内容。
[版权声明] 本站所有资料为用户分享产生,若发现您的权利被侵害,请联系客服邮件isharekefu@iask.cn,我们尽快处理。 本作品所展示的图片、画像、字体、音乐的版权可能需版权方额外授权,请谨慎使用。 网站提供的党政主题相关内容(国旗、国徽、党徽..)目的在于配合国家政策宣传,仅限个人学习分享使用,禁止用于任何广告和商用目的。

历史搜索

    清空历史搜索